Browse pathways

SARS coronavirus and innate immunity

SARS-CoV-2 altering angiogenesis via NRP1

SARS-CoV-2 and ACE2 receptor: molecular mechanisms

SARS-CoV-2 and COVID-19 pathway

SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation

SARS-CoV-2 innate immunity evasion and cell-specific immune response

SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction

SARS-CoV-2 replication organelle formation

SCFA and skeletal muscle substrate metabolism

Sebaleic acid formation and metabolism